The innovation company of the year wants to encourage young talents. Six students from Ullern Upper Secondary School spent their school day at Thermo Fisher Scientific just days after the company won the prestigious award as the innovation company of the year in Norway. As part of the school collaboration between Ullern Upper Secondary School and […]
Author Archive for: oslocancer
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 293 entries.
Entries by oslocancer
A new Norwegian research collaboration helps uncover what treatments are the right fit for American cancer patients. Who are the collaborators and what are they doing? There’s a lot of excitement and optimism concerning immuno-oncology, where the method is to utilize a person’s own immune system to treat cancer. However, excitement aside, methods such as this are often a costly experience, […]
Stanford programme SPARK provides a shimmer of hope for startup companies. Now, SPARK sets sights on Norway. What exactly is SPARK? We live in a world where technological and innovative solutions in medicine and healthcare are steadily pouring in. Not to mention, these solutions have the power to completely transform the health-sector in pinpointing and […]
Photocure reveals promising results in bladder cancer through the use of Blue Light Cytoscopy alongside the drug Hexvix. Bladder cancer endangers 167,000 people in Europe annually followed by over 59,000 deaths. Men are especially at risk, where a staggering 75% of bladder cancer cases occur. Not only that, but bladder cancer has a reputation as being one […]
On the 15th of August, drug Kadycla (trastuzumab emtansin) is finally approved by the Beslutningsforum and ready to help hundreds with breast cancer in Norway. The drug, developed by company Roche, specifically targets patients with the variant HER2 positive breast cancer – a breast cancer that tests positive for human epidermal growth factor receptor 2, […]
We are proud to introduce Oslo Cancer Cluster’s new members. This is the second part of two stories about our new members. You can find the first part HERE. On the 24th of August, Oslo Cancer Cluster hosted a bustling summer party in the Oslo Cancer Cluster Incubator, where the new members had the chance to introduce […]
We are proud to introduce Oslo Cancer Cluster’s new members. This is the first part of two stories about our new members. You can find the second part HERE. On the 24th of August, Oslo Cancer Cluster hosted a summer party with the intention of getting to know their newest members in an informative and fun […]
The Research Council of Norway has given Thermo Fisher Scientific the prestigious Innovation Award for their Dynabeads. The Oslo Cancer Cluster member Thermo Fischer Scientific was awarded the prize for developing an entirely new variant of an existing product, making it possible to analyse human genes quickly and effectively and improve diagnostic testing and patient […]
Sentrale fagmiljøer og helsepolitikere møttes på Oslo Cancer Clusters første åpne møte under Arendalsuka. De diskuterte hva persontilpasset medisin har potensial til å være – og hva som skal til for å oppnå resultater av forskning og klinisk bruk. Hva er egentlig persontilpasset medisin? Det handler enkelt forklart om at forebygging og behandling av sykdom […]
Interested pupils at Ullern Upper Secondary School arrive at laboratory 117 to learn alongside Dr. Bora Sieng, a chemist in Arctic Pharma. Dr. Sieng advocates for the importance of chemistry and encourages pupils to pursue a career in the exciting field of chemistry. At nine o’clock in the morning, three boys eagerly gather outside laboratory room 117. They’re […]
Contact Team >
Oslo Cancer Cluster Incubator will support promising oncology biotechs to commercialize successfully.
The Incubator provides a dynamic, creative, and professional growth environment for scientists and start-ups.